Header Logo

Michael Nikolaou

Concepts (76)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anti-Bacterial Agents
10
2023
183
1.800
 Why?
Models, Biological
7
2011
131
1.290
 Why?
Pseudomonas aeruginosa
7
2012
34
1.290
 Why?
Bacteria
3
2023
52
1.040
 Why?
Amikacin
2
2022
7
0.870
 Why?
Anti-Infective Agents
3
2011
15
0.850
 Why?
Ceftazidime
1
2022
9
0.790
 Why?
Epidemics
1
2022
5
0.770
 Why?
Communicable Diseases
1
2022
6
0.770
 Why?
Models, Theoretical
6
2022
78
0.650
 Why?
Microbial Sensitivity Tests
10
2022
99
0.600
 Why?
Acinetobacter baumannii
4
2014
12
0.580
 Why?
Thienamycins
3
2007
6
0.580
 Why?
Microbial Viability
2
2011
12
0.360
 Why?
Humans
11
2023
5476
0.330
 Why?
Scleral Buckling
1
2009
1
0.320
 Why?
Retinal Detachment
1
2009
3
0.320
 Why?
Body Fluids
1
2009
5
0.320
 Why?
Aminoglycosides
1
2008
17
0.300
 Why?
Levofloxacin
2
2011
3
0.300
 Why?
Ofloxacin
2
2011
5
0.290
 Why?
Dose-Response Relationship, Drug
4
2011
53
0.290
 Why?
beta-Lactamase Inhibitors
2
2021
10
0.270
 Why?
Drug Resistance, Bacterial
4
2012
16
0.260
 Why?
Acinetobacter Infections
2
2014
8
0.200
 Why?
Lactams
1
2021
2
0.180
 Why?
HIV Infections
1
2023
115
0.170
 Why?
Klebsiella pneumoniae
2
2012
12
0.160
 Why?
Colony Count, Microbial
2
2007
13
0.130
 Why?
Models, Statistical
2
2014
70
0.120
 Why?
Carbapenems
1
2014
8
0.110
 Why?
Escherichia coli
2
2011
111
0.100
 Why?
Imipenem
1
2012
3
0.100
 Why?
Azabicyclo Compounds
1
2012
7
0.090
 Why?
Energy Metabolism
1
2012
18
0.090
 Why?
Pneumonia, Bacterial
1
2011
5
0.090
 Why?
Neutrophils
1
2011
19
0.090
 Why?
Computer Simulation
2
2012
188
0.090
 Why?
Pseudomonas Infections
1
2011
19
0.090
 Why?
Fluoroquinolones
1
2011
4
0.090
 Why?
Staphylococcus aureus
1
2011
20
0.090
 Why?
Area Under Curve
1
2011
18
0.090
 Why?
Drug Design
1
2011
16
0.090
 Why?
Vitreous Body
1
2009
3
0.080
 Why?
Binomial Distribution
1
2009
3
0.080
 Why?
Finite Element Analysis
1
2009
8
0.080
 Why?
Viscosity
1
2009
11
0.080
 Why?
Saccades
1
2009
17
0.080
 Why?
Drug Combinations
2
2023
25
0.080
 Why?
Gentamicins
1
2008
3
0.080
 Why?
Drug Resistance, Microbial
1
2005
6
0.060
 Why?
Population Dynamics
1
2005
10
0.060
 Why?
Half-Life
1
2023
9
0.050
 Why?
Algorithms
1
2005
276
0.050
 Why?
beta-Lactamases
1
2021
13
0.040
 Why?
Time Factors
2
2012
176
0.040
 Why?
beta-Lactam Resistance
1
2014
6
0.030
 Why?
Cross Infection
1
2014
19
0.030
 Why?
Prevalence
1
2014
72
0.030
 Why?
Risk Factors
1
2014
184
0.030
 Why?
Reproducibility of Results
1
2014
350
0.020
 Why?
Drug Administration Schedule
1
2012
6
0.020
 Why?
Membranes, Artificial
1
2012
10
0.020
 Why?
Bacterial Load
1
2012
8
0.020
 Why?
Klebsiella Infections
1
2012
7
0.020
 Why?
Practice Guidelines as Topic
1
2012
20
0.020
 Why?
Immunocompromised Host
1
2011
2
0.020
 Why?
Cyclophosphamide
1
2011
3
0.020
 Why?
Aza Compounds
1
2011
2
0.020
 Why?
Quinolines
1
2011
21
0.020
 Why?
Piperacillin
1
2010
3
0.020
 Why?
beta-Lactams
1
2010
12
0.020
 Why?
Mutation
1
2011
137
0.020
 Why?
Mice
1
2011
719
0.020
 Why?
Animals
1
2011
1817
0.010
 Why?
Female
1
2011
2811
0.010
 Why?
Nikolaou's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (76)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_